Suscribirse

Radiology indispensable for tracking COVID-19 - 23/01/21

Doi : 10.1016/j.diii.2020.11.008 
Jingwen Li a, 1, Xi Long b, 1, Xinyi Wang a, Fang Fang c, Xuefei Lv c, Dandan Zhang c, Yu Sun c, Shaoping Hu c, Zhicheng Lin d, Nian Xiong a, e,
a Department of Neurology, Tongji Medical College, Huazhong University of Science and Technology, Union Hospital, Wuhan, Hubei, China 
b Department of Radiology, Tongji Medical College, Huazhong University of Science and Technology, Union Hospital, Wuhan, Hubei, China 
c Department of Radiology, Wuhan Red Cross Hospital, Wuhan, Hubei, China 
d Harvard Medical School, Mclean Hospital, 02478 Belmont, MA, USA 
e Wuhan Red Cross Hospital, Wuhan, Hubei, China 

Corresponding author at: Department of Neurology, Tongji Medical College, Huazhong University of Science and Technology, Union Hospital, Wuhan, Hubei, China.Department of Neurology, Tongji Medical College, Huazhong University of Science and Technology, Union hospitalWuhan, HubeiChina

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.

Conéctese para beneficiarse!

Highlights

Currently, chest computed tomography is recommended as the first-line imaging test for detecting COVID-19 pneumonia.
The most typical CT imaging finding of COVID-19 patients is ground-glass opacity, combined with reticular and/or interlobular septal thickening and consolidation.
CT is useful for monitoring patients with COVID-19, identifying associated vascular abnormalities and making differential diagnosis.

El texto completo de este artículo está disponible en PDF.

Abstract

With the rapid spread of COVID-19 worldwide, early detection and efficient isolation of suspected patients are especially important to prevent the transmission. Although nucleic acid testing of SARS-CoV-2 is still the gold standard for diagnosis, there are well-recognized early-detection problems including time-consuming in the diagnosis process, noticeable false-negative rate in the early stage and lacking nucleic acid testing kits in some areas. Therefore, effective and rational applications of imaging technologies are critical in aiding the screen and helping the diagnosis of suspected patients. Currently, chest computed tomography is recommended as the first-line imaging test for detecting COVID-19 pneumonia, which could allow not only early detection of the typical chest manifestations, but also timely estimation of the disease severity and therapeutic effects. In addition, other radiological methods including chest X-ray, magnetic resonance imaging, and positron emission computed tomography also show significant advantages in the detection of COVID-19 pneumonia. This review summarizes the applications of radiology and nuclear medicine in detecting and diagnosing COVID-19. It highlights the importance for these technologies to curb the rapid transmission during the pandemic, considering findings from special groups such as children and pregnant women.

El texto completo de este artículo está disponible en PDF.

Keywords : Artificial intelligence, COVID-19, Tomography, X-ray computed, Magnetic resonance imaging, Positron emission tomography computed tomography.

Abbreviations : AI, COVID-19, CT, 18F-FDG, GGO, HRCT, MRI, PET/CT, RT-PCR, SARS, UTE


Esquema


© 2020  The Authors. Publicado por Elsevier Masson SAS. Todos los derechos reservados.
Añadir a mi biblioteca Eliminar de mi biblioteca Imprimir
Exportación

    Exportación citas

  • Fichero

  • Contenido

Vol 102 - N° 2

P. 69-75 - février 2021 Regresar al número
Artículo precedente Artículo precedente
  • Proposals for the use of artificial intelligence in emergency radiology
  • Thibaut Jacques, Laure Fournier, Marc Zins, Catherine Adamsbaum, Kathia Chaumoitre, Antoine Feydy, Ingrid Millet, Michel Montaudon, Jean-Paul Beregi, Jean-Michel Bartoli, Philippe Cart, Jean-Philippe Masson, Jean-François Meder, Louis Boyer, Anne Cotten
| Artículo siguiente Artículo siguiente
  • COVID-19: A qualitative chest CT model to identify severe form of the disease
  • Antoine Devie, Lukshe Kanagaratnam, Jeanne-Marie Perotin, Damien Jolly, Jean-Noël Ravey, Manel Djelouah, Christine Hoeffel

Bienvenido a EM-consulte, la referencia de los profesionales de la salud.

Mi cuenta


Declaración CNIL

EM-CONSULTE.COM se declara a la CNIL, la declaración N º 1286925.

En virtud de la Ley N º 78-17 del 6 de enero de 1978, relativa a las computadoras, archivos y libertades, usted tiene el derecho de oposición (art.26 de la ley), el acceso (art.34 a 38 Ley), y correcta (artículo 36 de la ley) los datos que le conciernen. Por lo tanto, usted puede pedir que se corrija, complementado, clarificado, actualizado o suprimido información sobre usted que son inexactos, incompletos, engañosos, obsoletos o cuya recogida o de conservación o uso está prohibido.
La información personal sobre los visitantes de nuestro sitio, incluyendo su identidad, son confidenciales.
El jefe del sitio en el honor se compromete a respetar la confidencialidad de los requisitos legales aplicables en Francia y no de revelar dicha información a terceros.


Todo el contenido en este sitio: Copyright © 2025 Elsevier, sus licenciantes y colaboradores. Se reservan todos los derechos, incluidos los de minería de texto y datos, entrenamiento de IA y tecnologías similares. Para todo el contenido de acceso abierto, se aplican los términos de licencia de Creative Commons.